The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2017

Filed:

May. 05, 2014
Applicant:

The Scripps Research Institute, La Jolla, CA (US);

Inventors:

Rong Xiang, San Diego, CA (US);

He Zhou, San Diego, CA (US);

Ralph A Reisfeld, La Jolla, CA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61J 1/05 (2006.01); A61K 39/00 (2006.01); A61K 6/00 (2006.01);
U.S. Cl.
CPC ...
A61J 1/05 (2013.01); A61K 6/00 (2013.01); A61K 39/0011 (2013.01); A61K 2039/523 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55522 (2013.01);
Abstract

A DNA vaccine suitable for eliciting an immune response against cancer cells comprises a DNA construct operably encoding a cancer-associated Inhibitor of Apoptosis-family protein and an immunoactive gene product, such as a cytokine or a ligand for a natural killer cell surface receptor, in a pharmaceutically acceptable carrier. A preferred cytokine is CCL21. Preferred ligands for a natural killer cell surface receptor include human MICA, human MICB, human ULBP1, human ULBP2, and human ULBP3. The cancer-associated Inhibitor of Apoptosis (IAP)-family protein is preferably a survivin protein or livin protein. Method of inhibiting tumor growth by administering the vaccine of the invention to a mammal is also described.


Find Patent Forward Citations

Loading…